Praxis Precision Medicines, Inc. (PRAX)

PRAX Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	2.45	0	0	0	0
Gross Profit	2.45	0	0	0	0
Selling, General & Admin	42.05	59.95	47.08	16.99	6.23
Research & Development	86.77	155.04	120.26	44.98	29.56
Operating Expenses	128.82	214.99	167.33	61.97	35.79
Operating Income	-126.37	-214.99	-167.33	-61.97	-35.79
Other Expense / Income	-3.1	-0.96	-0.27	-0.14	-0.19
Pretax Income	-123.28	-214.03	-167.06	-61.83	-35.6
Income Tax	0	0	0	-0.01	-0.08
Net Income	-123.28	-214.03	-167.06	-61.82	-35.51
Preferred Dividends	0	0	0	8.5	5.17
Net Income Common	-123.28	-214.03	-167.06	-70.32	-40.68
Shares Outstanding (Basic)	7	3	3	1	0
Shares Outstanding (Diluted)	7	3	3	1	0
Shares Change	114.58%	8.58%	374.34%	485.12%	17.88%
EPS (Basic)	-18.69	-69.65	-59.10	-117.90	-399.00
EPS (Diluted)	-18.69	-69.65	-59.10	-117.90	-399.00
Free Cash Flow	-111.19	-185.49	-125.6	-52.62	-33.52
Free Cash Flow Per Share	-16.86	-60.36	-44.38	-88.19	-328.74
Gross Margin	100.00%	-	-	-	-
Operating Margin	-5164.41%	-	-	-	-
Profit Margin	-5037.88%	-	-	-	-
Free Cash Flow Margin	-4543.77%	-	-	-	-
EBITDA	-122.01	-212.86	-165.47	-61.08	-34.92
EBITDA Margin	-4986.02%	-	-	-	-
Depreciation & Amortization	1.27	1.17	1.59	0.75	0.68
EBIT	-123.28	-214.03	-167.06	-61.83	-35.6
EBIT Margin	-5037.88%	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).